In addition, MiR‐203 can enhances 5‐FU chemosensitivity via the down‐regulation of TYMS in colorectal cancer 42 and drive progression of prostate cancer by suppressing LASP1 43. This evidence concerns the gene LASP1 and prostate cancer.